The Medication-Assisted Treatment (MAT) program is a critical intervention in addressing the widespread drug epidemic within prison systems, especially for incarcerated individuals grappling with addiction. MAT combines medications such as methadone, buprenorphine, or naltrexone with counseling and behavioral therapies to treat substance use disorders effectively. Kali's reflections underscore the daily realities faced by incarcerated women who navigate the complexities of addiction behind bars. Prisons often become hotspots for drug use due to factors like limited access to treatment, stress, and the challenge of maintaining sobriety in an environment saturated with illicit substances. MAT programs within these facilities play an essential role in reducing withdrawal symptoms, curbing cravings, and ultimately helping individuals regain control over their lives. Implementing MAT in prisons not only benefits the individual but also contributes to overall institutional safety by decreasing incidents related to drug seeking and illicit use. Moreover, MAT programs have shown to reduce recidivism rates, as sustained treatment encourages better reintegration into society post-release. Supporting incarcerated women through MAT acknowledges their unique vulnerabilities, including trauma histories and mental health needs, which often intersect with substance abuse. Tailored approaches ensure that treatment is compassionate and effective, addressing underlying causes rather than merely symptoms. Awareness and advocacy for MAT programs in prisons continue to grow, spotlighting the urgent need for expanded access, funding, and education among correctional staff and inmates alike. Personal testimonies like Kali’s lend important voices to the conversation, illustrating the human side of addiction and recovery inside correctional facilities.